SCHEMBL8339276

SCHEMBL8339276

CCC(=O)c1ccc(-c2ccc(-c3csc(C(=O)NCc4ccc(CC(=O)O)cc4)c3)cc2)cc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 5/20 0.75
NR1H4 Q96RI1 4/20 0.47
EPHX2 P34913 3/20 0.47
MAPK1 P28482 2/20 0.43
MAPT P10636 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
RORC P51449 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41
HDAC5 Q9UQL6 1/20 0.41
NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8338023 0.87 MMP12 (0.57) MMP12EPHX2MAPK1MAPTSMN1; SMN2
SCHEMBL8339549 0.85 MMP12 (0.72) MMP12NR1H4EPHX2MAPK1RORC
SCHEMBL8341227 0.83 MMP12 (0.77) MMP12MAPK1MAPTSMN1; SMN2HDAC3
SCHEMBL6873364 0.82 MMP12 (0.74) MMP12NR1H4EPHX2MAPK1RORC
SCHEMBL6880697 0.82 MMP12 (0.78) MMP12NR1H4EPHX2MAPK1RORC
SCHEMBL8342537 0.81 MMP12 (0.77) MMP12NR1H4EPHX2MAPK1RORC
SCHEMBL6874960 0.81 MMP12 (0.77) MMP12NR1H4EPHX2MAPK1RORC
SCHEMBL6874687 0.80 MMP12 (0.83) MMP12EPHX2SMN1; SMN2RORCNPC1
SCHEMBL6873463 0.80 MMP12 (0.71) MMP12NR1H4EPHX2MAPK1RORC
SCHEMBL6875476 0.80 MMP12 (0.71) MMP12NR1H4EPHX2MAPK1RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004018448-A1 NOVEL THIOPHENE DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME WARNER-LAMBERT COMPANY LLC (US) 2004-03-04 WO disclosed